These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4307672)

  • 1. Alteration in virulence in strains of Cryptococcus neoformans resistant to amphotericin B and polymyxin B.
    Bodenhoff J
    Acta Pathol Microbiol Scand; 1969; 75(1):153-68. PubMed ID: 4307672
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.
    Schwarz P; Dromer F; Lortholary O; Dannaoui E
    Antimicrob Agents Chemother; 2006 Jan; 50(1):113-20. PubMed ID: 16377675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic response to capsule-deficient Cryptococcus neoformans.
    Farmer SG; Komorowski RA
    Arch Pathol; 1973 Dec; 96(6):383-7. PubMed ID: 4594090
    [No Abstract]   [Full Text] [Related]  

  • 4. Incorporation of amphotericin B in tuftsin-bearing liposomes showed enhanced efficacy against systemic cryptococcosis in leucopenic mice.
    Khan MA; Nasti TH; Owais M
    J Antimicrob Chemother; 2005 Oct; 56(4):726-31. PubMed ID: 16126780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of strains of Cryptococcus neoformans resistant to nystatin, amphotericin B, trichomycin and polymyxin B.
    Bodenhoff J
    Acta Pathol Microbiol Scand; 1968; 73(4):572-82. PubMed ID: 4301525
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pathogenicity of vaccinia virus for the rat].
    Jandásek L
    Zentralbl Bakteriol Orig; 1968; 207(2):172-7. PubMed ID: 5745202
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro sensitivity to amphotericin B of Cryptococcus neoformans isolated in Thailand.
    Gaew-Im M; Thasnakorn P
    J Med Assoc Thai; 1971 Jan; 54(6):405-9. PubMed ID: 5171413
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased susceptibility of Cryptococcus neoformans to amphotericin B in the presence of steroids.
    Mohr JA; Tatem BA; Long H; Muchmore HG; Felton FG
    Sabouraudia; 1973 Jul; 11(2):140-2. PubMed ID: 4584201
    [No Abstract]   [Full Text] [Related]  

  • 9. [Isolation and characteristics of polymyxin-resistant mutants of Shigella flexneri].
    Marakusha BI
    Antibiotiki; 1980 Oct; 25(10):753-8. PubMed ID: 6252826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of pathogenicity of Cryptococcus neoformans serotypes A, D and AD in murine cryptococcosis.
    Barchiesi F; Cogliati M; Esposto MC; Spreghini E; Schimizzi AM; Wickes BL; Scalise G; Viviani MA
    J Infect; 2005 Jul; 51(1):10-6. PubMed ID: 15979484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptococcal meningitis treated with 5-fluorocytosine and amphotericin B.
    Halkin H; Ravid M; Zulman J; Reichert N
    Isr J Med Sci; 1974 Sep; 10(9):1148-52. PubMed ID: 4611967
    [No Abstract]   [Full Text] [Related]  

  • 12. [Primary meningitis due to Cryptococcus neoformans associated with polyradiculitis. Cure by amphotericin B].
    Bastin R; Vildé JL; Drouhet E; Carbon C
    Sem Hop; 1974 Jan; 50(5):337-43. PubMed ID: 4368225
    [No Abstract]   [Full Text] [Related]  

  • 13. Filamentation and endogenous sporulation in Cryptococcus neoformans.
    Gordon MA; Devine J
    Sabouraudia; 1970 Nov; 8(3):227-34. PubMed ID: 4099976
    [No Abstract]   [Full Text] [Related]  

  • 14. [Isolation of Cryptococcus gattii serotype B from detritus of Eucalyptus trees in Colombia].
    Escandón P; Quintero E; Granados D; Huérfano S; Ruiz A; Castañeda E
    Biomedica; 2005 Sep; 25(3):390-7. PubMed ID: 16276686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of infection in mice inoculated intranasally with Cryptococcus neoformans.
    Anderson DA; Sagha HM
    Mycopathologia; 1988 Dec; 104(3):163-9. PubMed ID: 3070384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
    Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Course of experimental cryptococcosis in albino mice during treatment with the antibiotic trichomycin (Preparation 1831-23].
    Medvedkova AA; Slonitskaia NN; Liubimova LK; Paĭkin MD; Frolova MA; Korik LM
    Antibiotiki; 1969 Jun; 14(7):639-43. PubMed ID: 5817692
    [No Abstract]   [Full Text] [Related]  

  • 18. Cryptococcus neoformans capsule structure evolution in vitro and during murine infection.
    Garcia-Hermoso D; Dromer F; Janbon G
    Infect Immun; 2004 Jun; 72(6):3359-65. PubMed ID: 15155641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluconazole-resistant Cryptococcus neoformans isolated from an immunocompetent patient without prior exposure to fluconazole.
    Orni-Wasserlauf R; Izkhakov E; Siegman-Igra Y; Bash E; Polacheck I; Giladi M
    Clin Infect Dis; 1999 Dec; 29(6):1592-3. PubMed ID: 10585832
    [No Abstract]   [Full Text] [Related]  

  • 20. Virulence, capsule size and lipid composition interrelation of Cryptococcus neoformans.
    Upreti HB; Rawat DS; Das SK
    Microbiologica; 1984 Oct; 7(4):371-4. PubMed ID: 6392831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.